| P2093 | author name string | Haider Ali Khan | |
| | Maha Abdulla | |
| | Sharjeel Usmani | |
| | Fahad Marafi | |
| | Najeeb Ahmed | |
| | Farida al Kandari | |
| | Fawaz abu Huda | |
| | Naheel al Nafisi | |
| | Shihab al Mohannadi | |
| P2860 | cites work | Imaging of neuroendocrine tumors | Q28245029 |
| | Standardisation of imaging in neuroendocrine tumours: results of a European delphi process | Q34198796 |
| | Neuroendocrine tumours | Q34306644 |
| | Positive somatostatin receptor scintigraphy correlates with the presence of somatostatin receptor subtype 2. | Q34409167 |
| | Prognostic factors in patients with endocrine tumours of the duodenopancreatic area | Q35352149 |
| | Functional-anatomical image fusion in neuroendocrine tumors. | Q35739761 |
| | Diagnostic uses of radiolabelled somatostatin receptor analogues in gastroenteropancreatic endocrine tumours | Q35743425 |
| | Recent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumours. | Q35833855 |
| | Somatostatin and other Peptide receptors as tools for tumor diagnosis and treatment | Q35915003 |
| | Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumours. | Q51571439 |
| | Surgery as primary treatment in patients with liver metastases from carcinoid tumors: a retrospective, unicentric study over 13 years. | Q53499868 |
| | 68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT | Q57757715 |
| P433 | issue | 4 | |
| P304 | page(s) | 356-361 | |
| P577 | publication date | 2011-05-11 | |
| P1433 | published in | Medical Principles and Practice | Q15759132 |
| P1476 | title | Incremental diagnostic value and impact on patient management of somatostatin receptor scintigraphy with indium-111-pentetreotide in gastroenteropancreatic neuroendocrine tumors. | |
| P478 | volume | 20 | |